Normophosphatemic familial tumoral calcinosis
| Normophosphatemic familial tumoral calcinosis | |
|---|---|
| Synonyms | NFTC |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Calcinosis, joint pain, swelling |
| Complications | Skin ulceration, infection |
| Onset | Childhood or adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in SAMD9 |
| Risks | Family history |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Hyperphosphatemic familial tumoral calcinosis, calciphylaxis |
| Prevention | N/A |
| Treatment | Surgical removal, pain management |
| Medication | Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | Rare |
A rare genetic disorder characterized by abnormal calcium deposits in the body
Normophosphatemic familial tumoral calcinosis (NFTC) is a rare genetic disorder characterized by the development of calcified masses in the soft tissues of the body. Unlike other forms of tumoral calcinosis, NFTC is distinguished by normal levels of phosphate in the blood.
Pathophysiology[edit]
NFTC is caused by mutations in the SAMD9 gene, which plays a role in regulating calcium and phosphate metabolism. The disorder leads to the formation of calcium deposits in the soft tissues, particularly around the joints. These deposits can cause pain, swelling, and reduced mobility.
Clinical Presentation[edit]
Patients with NFTC typically present with firm, painless masses near the joints, such as the hips, elbows, and shoulders. These masses can vary in size and may become painful if they compress surrounding structures. Unlike other forms of tumoral calcinosis, patients with NFTC have normal serum phosphate levels.
Diagnosis[edit]
The diagnosis of NFTC is based on clinical examination, imaging studies, and genetic testing. X-rays and CT scans can reveal the extent of calcification. Genetic testing can confirm mutations in the SAMD9 gene, which are responsible for the condition.
Management[edit]
There is no specific cure for NFTC, and treatment is primarily symptomatic. Surgical removal of the calcified masses may be considered if they cause significant discomfort or functional impairment. Pain management and physical therapy can help improve mobility and quality of life.
Prognosis[edit]
The prognosis for individuals with NFTC varies. Some patients may experience recurrent calcifications after surgical removal, while others may have stable disease with minimal symptoms. Regular monitoring and supportive care are essential to manage the condition effectively.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian